Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Kitov Pharma Ltd (KTOV)

0.8208   -0.031 (-3.66%) 07-10 16:00
Open: 0.8322 Pre. Close: 0.852
High: 0.84 Low: 0.8
Volume: 11,239,923 Market Cap: 132M
Kitov Pharma Ltd, through its subsidiaries, operates as a development stage biopharmaceutical company in Israel. The company operates through two segments, Pain and Hypertension; and Oncology. It develops combination drugs for the simultaneous treatment of pain caused by osteoarthritis and hypertension. The company's lead drug candidate is Consensi a combination of APIs celecoxib and amlodipine besylate. It is also developing NT219, a small molecule that targets two oncology-related proteins to overcome resistance to cancer drug treatment. The company was formerly known as Kitov Pharmaceuticals Holdings Ltd. and changed its name to Kitov Pharma Ltd in January 2018. Kitov Pharma Ltd was founded in 2010 and is headquartered in Tel Aviv, Israel.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.842 - 0.846 0.846 - 0.852
Low: 0.787 - 0.792 0.792 - 0.798
Close: 0.81 - 0.819 0.819 - 0.829

Technical analysis

as of: 2020-07-10 4:29:43 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 1.23     One year: 1.68
Support: Support1: 0.42    Support2: 0.35
Resistance: Resistance1: 1.05    Resistance2: 1.44
Pivot: 0.92
Moving Average: MA(5): 0.84     MA(20): 0.81
MA(100): 0.50     MA(250): 0.66
MACD: MACD(12,26): 0.09     Signal(9): 0.11
Stochastic oscillator: %K(14,3): 40.65     %D(3): 40.37
RSI: RSI(14): 52.72
52-week: High: 1.44  Low: 0.22  Change(%): -12.0
Average Vol(K): 3-Month: 3379714  10-Days: 4238751

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
KTOV has closed above bottom band by 36.2%. Bollinger Bands are 126.6% wider than normal. The large width of the bands suggest high volatility as compared to KTOV's normal range. The bands have been in this wide range for 13 bars. This is a sign that the current trend might continue.

Headline News

Thu, 09 Jul 2020
Kitov Announces Initiation of Phase 1/2 Clinical Trial of NT219 in Advanced Cancer Patients - GlobeNewswire

Wed, 08 Jul 2020
Kitov Pharma Receives Notice of Intention to Grant a European Patent Covering CM24, its anti-CEACAM1 Antibody - Yahoo Finance

Tue, 07 Jul 2020
Fresh Data-Based Insight On Kitov Pharma Ltd (KTOV) - Stocks Register

Mon, 06 Jul 2020
Ties With Merck Could Explain Kitov's Market Interest - Seeking Alpha

Thu, 02 Jul 2020
Kitov Pharma Issues CEO Shareholder Letter Providing Business Update - GlobeNewswire

Wed, 01 Jul 2020
Kitov's $35 Million Shares Offering - Global Legal Chronicle

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 118
Shares Float (M) 33
% Held by Insiders 4.67
% Held by Institutions 28.19
Shares Short (K) 4,760
Shares Short P. Month (K) 2,560

Stock Financials

EPS -0.302
EPS Est This Year -1.040
EPS Est Next Year -0.400
Book Value (p.s.) 0.530
Profit Margin
Operating Margin -680.00
Return on Assets (ttm) -28.9
Return on Equity (ttm) -53.9
Qtrly Rev. Growth
Gross Profit (p.s.) 0.008
Sales Per Share 0.008
EBITDA (p.s.) -0.057
Qtrly Earnings Growth
Operating Cash Flow (M) -6
Levered Free Cash Flow (M) -5

Stock Valuations

PE Ratio -2.72
PEG Ratio
Price to Book value 1.55
Price to Sales 97.15
Price to Cash Flow -17.41

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.